Title	Source
Lessons for COVID-19 Immunity from Other Coronavirus Infections	ScienceDirect
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma	ScienceDirect
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial	ScienceDirect
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection	American Society of Hematology
Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study	ScienceDirect
Characteristics of patients with coronavirus disease (COVID-19) confirmed using an IgM-IgG antibody test	Wiley Online Library
Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial	Jama Network
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19	The New England Journal of Medicine
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial	Jama Network
Serological differentiation between COVID-19 and SARS infections	Taylor & Francis Online
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study	ScienceDirect
Kinetics of viral load and antibody response in relation to COVID-19 severity	The Journal of Clinical Investigation
Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID-19	ASCPT
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial	BMJ Journals
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial	ScienceDirect
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial	ScienceDirect
SMulti-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19	ScienceDirect
An mRNA Vaccine against SARS-CoV-2 – Preliminary Report	The New England Journal of Medicine
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial	ScienceDirect
Scent dog identification of samples from COVID-19 patients – a pilot study	BMC Infectious Diseases
Phylogenomic analysis of SARS-CoV-2 genomes from western India reveals unique linked mutations	biorxiv
Identification of bioactive molecules from Tea plant as SARS-CoV-2 main protease inhibitors	Taylor & Francis Online
Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals	Cell
What did we learn from the novel coronavirus genomes from India ?	Genomeconnect
Infection of dogs with SARS-CoV-2	nature
Dogs caught coronavirus from their owners, genetic analysis suggests	nature
Dozens of coronavirus drugs are in development — what happens next?	nature
Coronavirus in charts: are virtual conferences here to stay?	nature
An interpretable mortality prediction model for COVID-19 patients	nature
Real-time tracking of self-reported symptoms to predict potential COVID-19	nature
Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis	biorxiv
Research Articles on COVID-19	Google Scholar
Publications	Centres for Disease Control & Prevention
COVID-19: a new challenge for human beings	nature
An interactive web-based dashboard to track COVID-19 in real time	The Lancet
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations	The Lancet